7DMU
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
Summary for 7DMU
Entry DOI | 10.2210/pdb7dmu/pdb |
Descriptor | Angiotensin-converting enzyme 2, Spike protein S1, alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (10 entities in total) |
Functional Keywords | sars-cov-2, covid-19, ace2, viral protein |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 4 |
Total formula weight | 196426.79 |
Authors | Arimori, T.,Takagi, J. (deposition date: 2020-12-07, release date: 2020-12-23, Last modification date: 2023-11-29) |
Primary citation | Higuchi, Y.,Suzuki, T.,Arimori, T.,Ikemura, N.,Mihara, E.,Kirita, Y.,Ohgitani, E.,Mazda, O.,Motooka, D.,Nakamura, S.,Sakai, Y.,Itoh, Y.,Sugihara, F.,Matsuura, Y.,Matoba, S.,Okamoto, T.,Takagi, J.,Hoshino, A. Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2. Nat Commun, 12:3802-3802, 2021 Cited by PubMed: 34155214DOI: 10.1038/s41467-021-24013-y PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.2 Å) |
Structure validation
Download full validation report